242 related articles for article (PubMed ID: 15146582)
1. [Vaccine adjuvants and macrophagic myofasciitis].
Siegrist CA
Bull Acad Natl Med; 2003; 187(8):1511-8; discussion 1519-21. PubMed ID: 15146582
[TBL] [Abstract][Full Text] [Related]
2. [Vaccine adjuvants and macrophagic myofasciitis].
Siegrist CA
Arch Pediatr; 2005 Jan; 12(1):96-101. PubMed ID: 15653065
[TBL] [Abstract][Full Text] [Related]
3. [Lessons from macrophagic myofasciitis: towards definition of a vaccine adjuvant-related syndrome].
Gherardi RK
Rev Neurol (Paris); 2003 Feb; 159(2):162-4. PubMed ID: 12660567
[TBL] [Abstract][Full Text] [Related]
4. Macrophagic myofasciitis in children is a localized reaction to vaccination.
Lach B; Cupler EJ
J Child Neurol; 2008 Jun; 23(6):614-9. PubMed ID: 18281624
[TBL] [Abstract][Full Text] [Related]
5. Macrophagic myofasciitis: a summary of Dr. Gherardi's presentations.
Brenner A
Vaccine; 2002 May; 20 Suppl 3():S5-6. PubMed ID: 12184366
[TBL] [Abstract][Full Text] [Related]
6. Distinctive clinical features in arthro-myalgic patients with and without aluminum hydroxyde-induced macrophagic myofasciitis: an exploratory study.
Ragunathan-Thangarajah N; Le Beller C; Boutouyrie P; Bassez G; Gherardi RK; Laurent S; Authier FJ
J Inorg Biochem; 2013 Nov; 128():262-6. PubMed ID: 23921285
[TBL] [Abstract][Full Text] [Related]
7. Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle.
Gherardi RK; Coquet M; Cherin P; Belec L; Moretto P; Dreyfus PA; Pellissier JF; Chariot P; Authier FJ
Brain; 2001 Sep; 124(Pt 9):1821-31. PubMed ID: 11522584
[TBL] [Abstract][Full Text] [Related]
8. Macrophagic myofasciitis and subcutaneous pseudolymphoma caused by aluminium adjuvants.
Kim H; Lim KY; Kang J; Park JW; Park SH
Sci Rep; 2020 Jul; 10(1):11834. PubMed ID: 32678281
[TBL] [Abstract][Full Text] [Related]
9. Blood oxidative stress status in patients with macrophagic myofasciitis.
Bonnefont-Rousselot D; Chantalat-Auger C; Teixeira A; Jaudon MC; Pelletier S; Cherin P
Biomed Pharmacother; 2004 Nov; 58(9):516-9. PubMed ID: 15511609
[TBL] [Abstract][Full Text] [Related]
10. Macrophagic myofasciitis in childhood: the role of scanning electron microscopy/energy-dispersive spectroscopy for diagnosis.
Kalil RK; Monteiro A; Lima MI; Silveira EB; Foltran FS; Martins CE; Rizzo IM
Ultrastruct Pathol; 2007; 31(1):45-50. PubMed ID: 17455097
[TBL] [Abstract][Full Text] [Related]
11. Aluminum adjuvants of vaccines injected into the muscle: Normal fate, pathology and associated disease.
Gherardi RK; Aouizerate J; Cadusseau J; Yara S; Authier FJ
Morphologie; 2016 Jun; 100(329):85-94. PubMed ID: 26948677
[TBL] [Abstract][Full Text] [Related]
12. Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction.
Couette M; Boisse MF; Maison P; Brugieres P; Cesaro P; Chevalier X; Gherardi RK; Bachoud-Levi AC; Authier FJ
J Inorg Biochem; 2009 Nov; 103(11):1571-8. PubMed ID: 19748679
[TBL] [Abstract][Full Text] [Related]
13. Macrophagic myofaciitis a vaccine (alum) autoimmune-related disease.
Israeli E; Agmon-Levin N; Blank M; Shoenfeld Y
Clin Rev Allergy Immunol; 2011 Oct; 41(2):163-8. PubMed ID: 20882368
[TBL] [Abstract][Full Text] [Related]
14. A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome.
Exley C; Swarbrick L; Gherardi RK; Authier FJ
Med Hypotheses; 2009 Feb; 72(2):135-9. PubMed ID: 19004564
[TBL] [Abstract][Full Text] [Related]
15. Myalgia and chronic fatigue syndrome following immunization: macrophagic myofasciitis and animal studies support linkage to aluminum adjuvant persistency and diffusion in the immune system.
Gherardi RK; Crépeaux G; Authier FJ
Autoimmun Rev; 2019 Jul; 18(7):691-705. PubMed ID: 31059838
[TBL] [Abstract][Full Text] [Related]
16. Polyglandular autoimmunity with macrophagic myofasciitis.
Theeler BJ; Simper NB; Ney JP
Clin Rheumatol; 2008 May; 27(5):667-9. PubMed ID: 18180978
[TBL] [Abstract][Full Text] [Related]
17. Cognitive dysfunction associated with aluminum hydroxide-induced macrophagic myofasciitis: A reappraisal of neuropsychological profile.
Aoun Sebaiti M; Kauv P; Charles-Nelson A; Van Der Gucht A; Blanc-Durand P; Itti E; Gherardi RK; Bachoud-Levi AC; Authier FJ
J Inorg Biochem; 2018 Apr; 181():132-138. PubMed ID: 29079320
[TBL] [Abstract][Full Text] [Related]
18. Macrophagic myofasciitis and vaccination: consequence or coincidence?
Santiago T; Rebelo O; Negrão L; Matos A
Rheumatol Int; 2015 Jan; 35(1):189-92. PubMed ID: 24923906
[TBL] [Abstract][Full Text] [Related]
19. Atypical presentation of macrophagic myofasciitis 10 years post vaccination.
Ryan AM; Bermingham N; Harrington HJ; Keohane C
Neuromuscul Disord; 2006 Dec; 16(12):867-9. PubMed ID: 17005400
[TBL] [Abstract][Full Text] [Related]
20. Aluminium assay and evaluation of the local reaction at several time points after intramuscular administration of aluminium containing vaccines in the Cynomolgus monkey.
Verdier F; Burnett R; Michelet-Habchi C; Moretto P; Fievet-Groyne F; Sauzeat E
Vaccine; 2005 Feb; 23(11):1359-67. PubMed ID: 15661384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
